[SPIO-labeled rat bone marrow mesenchymal stem cells: alterations of biological activity and labeling efficiency

Insights

Polylysine-coated superparamagnetic iron oxide (PLL-SPIO) effectively labels rat mesenchymal stem cells for MRI tracking. The labeled cells maintained their differentiation potential and showed no cytotoxicity, indicating PLL-SPIO as a promising MRI contrast agent.

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Radiology

Background:

  • Tracking transplanted cells non-invasively is crucial for regenerative medicine.
  • Superparamagnetic iron oxide nanoparticles (SPIONs) are potential contrast agents for Magnetic Resonance Imaging (MRI).
  • Polylysine coating can enhance SPIONs' biocompatibility and cellular uptake.

Purpose of the Study:

  • To characterize and evaluate polylysine-coated superparamagnetic iron oxide (PLL-SPIO) for labeling and tracking rat mesenchymal stem cells (rMSCs) using MRI.
  • To assess the impact of PLL-SPIO labeling on rMSC cytotoxicity and differentiation potential.
  • To determine the optimal concentration of PLL-SPIO for effective in vitro MRI tracking.

Main Methods:

  • Rat bone marrow derived mesenchymal stem cells (rMSCs) were labeled with varying concentrations of PLL-SPIO (25, 50, 100 microg/mL).
  • Labeling efficiency was assessed via iron content, Prussian blue staining, and electron microscopy.
  • Cytotoxicity and in vitro differentiation (adipo/osteo/chondrogenic) potential were evaluated.
  • In vitro MRI was performed on labeled cells using T1W, T2WI, and T2*WI sequences.

Main Results:

  • Electron microscopy and Prussian blue staining confirmed 75%-100% labeling efficiency.
  • PLL-SPIO exhibited no cytotoxicity up to 100 microg/mL.
  • rMSCs labeled with 25 and 50 microg/mL PLL-SPIO showed no significant alterations in differentiation potential.
  • A concentration of 25 microg/mL PLL-SPIO produced a clear dark signal in all MRI sequences.

Conclusions:

  • Novel PLL-SPIO effectively labels rMSCs for in vitro MRI tracking without compromising cell viability or function.
  • PLL-SPIO demonstrates potential as an MRI contrast agent for tracking transplanted cells.
  • This method offers a promising approach for monitoring cell therapies non-invasively.

Related Concept Videos